ROWASA OD TABLET contains Mesalamine which belongs to the group of medicines called Salicylates. ROWASA OD TABLET is used to manage mild to moderate ulcerative colitis (a chronic inflammatory bowel disease) in affected individuals.
ROWASA OD TABLET is also used to reduce symptoms of ulcerative colitis which generally occurs as diarrhoea, rectal bleeding, and/or stomach pain in affected individuals.
ROWASA OD TABLET is not recommended for use in patients allergic to Mesalamine, salicylates (such as acetylsalisylic acid), and/or sulphasalazine. It is also not recommended for use in patients with serious kidney/liver disease.
Before taking [GBKEYWORD], inform your doctor if you have narrowing/blockage of stomach/gut, lung problems, and/or mild to moderate kidney/liver problems.
ROWASA OD TABLET should be used with caution in pregnant and breastfeeding women only if it is clearly necessary. ROWASA OD TABLET is not recommended for use in children and adolescents aged below 18 years (due to lack of data on safety and efficacy of the medicine). It is advised to be used with caution in elderly patients (aged above 65 years) after consulting the doctor.
The most common side effects of taking ROWASA OD TABLET are indigestion, abdominal pain, nausea, vomiting, diarrhoea, headache, itching, and/or rash. Consult your doctor if any of these symptoms worsens.
No content available
